[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences (NBIX) stock hits a 52-week high driven by strong INGREZZA sales, despite a slight miss on EPS estimates. Analysts remain positive, raising price targets due to robust product performance and successful launches.

### About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.  
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Neurocrine Biosciences, Inc. (NBIX) trading volume is up XXXXX% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) social dominance is up XXXXXX% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) sentiment is up XXX% from the previous X months.
- Neurocrine Biosciences, Inc. (NBIX) engagements is up XXXXX% from the previous week.
- Neurocrine Biosciences, Inc. Price hit a 52-Week high of $XXXXXX for the hour
- Neurocrine Biosciences, Inc. Price hit an all time of $XXXXXX for the hour

### Price: $XXXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/close.tsv)  
The stock price recently hit a 52-week high, driven by strong Q3 results and record INGREZZA sales. While missed EPS estimates introduced some minor downward pressure, the overall sentiment remains positive due to strong product performance and successful launches, with analysts raising price targets.  

24-Hour: -XXXX%
7-Day: XXXX%
30-Day: XXX%

1-Year High: $XXXXXX on 2025-12-10  
1-Year Low: $XXXXX on 2025-04-08  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/alt_rank.tsv)  
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #1,078 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXXXX +387  
X Month: XXXXX +731  
X Months: XXXXX +1,020  
X Year: XXXXX +934  
1-Year High: XXXXX on 2025-09-25  
1-Year Low: XX on 2025-05-06  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -XX  
X Month: XX -XX  
X Months: XX -XX  
X Year: XX -XX  
1-Year High: XX on 2025-01-13  
1-Year Low: X on 2025-09-24  
  
  
### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXXX  
X Week: XXXXX +18%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXX +17%  
X Year: XXXXXXXXX +15%  
1-Year High: XXXXXXX on 2025-05-05  
1-Year Low: XXX on 2025-12-06  

Engagements by network (24h):
Reddit: X
X: XXX
YouTube: X

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXX -XX%  
X Months: XXXXXX +438%  
X Year: XXXXXX +333%  
1-Year High: XXXXX on 2025-07-03  
1-Year Low: XX on 2025-12-07  

Mentions by network (24h):
Reddit: X
X: XXX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XXX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +1,131%  
X Year: XXXXXX +834%  
1-Year High: XXXXX on 2025-07-03  
1-Year Low: XX on 2025-12-07  

The most influential creators that mention Neurocrine Biosciences, Inc. in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | X    | XXXXX     | X     | XXX         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XXX         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | X    | XX        | X     | XXX         |
| [@monaco_biotech](/creator/twitter/monaco_biotech)   | X    | XXXXX     | X     | XX          |
| [@seedytx19](/creator/twitter/seedytx19)             | X    | XXXXX     | X     | X           |

[View More](/list/creators/neurocrine-biosciences-inc/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% +33%  
X Month: XXX% +38%  
X Months: XXX% +30%  
X Year: XXX% +46%  
1-Year High: XXX% on 2025-07-20  
1-Year Low: XX% on 2025-09-13  

Most Supportive Themes:
- Ingrezza Sales Growth: (40%) Ingrezza sales are increasing market penetration and revenue.
- Crenessity Phase X Study: (35%) Positive outcomes from the Crenessity Phase X study boost confidence in Neurocrine's pipeline.
- Affordable Growth Potential: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value.
  
Most Critical Themes:
- Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXX%  
X Week: XXXXXX% +0.0055%  
X Month: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%  
X Months: XXXXXX% -XXXXX%  
X Year: XXXXXX% -XXXXX%  
1-Year High: XXXXX% on 2025-07-03  
1-Year Low: XXXXXX% on 2025-12-07  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-04-09  
1-Year Low: XXXXX% on 2025-04-14  
  
  
### Market Cap: $XXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXX +$1.30%  
X Month: $XXXXXXXXXXXXXX +$4.20%  
X Months: $XXXXXXXXXXXXXX +$24%  
X Year: $XXXXXXXXXXXXXX +$18%  
1-Year High: $XXXXXXXXXXXXXX on 2025-01-30  
1-Year Low: $XXXXXXXXXXXXX on 2025-04-12  

### Top Neurocrine Biosciences, Inc. Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"New Highs : $AVGO $COLL $FIX $KRYS $LITE $TTMI $AUGO $BELFA $BELFB $CVNA $COHR $FIGS $FCAP $IESC $IRMD $FROG $NBIX $PWR $SND $PATH $VIAV $ARQT $ENVA $MTZ $MDB $RY $SMTC $BCAL $TRX $ALMS $FIVE $HTBK $MS $NUTX $ANAB $NTB $BK $EBC $ECPG $BE $JBL $NVT $NVT $PRIM $VRT $MSFT $FIVE:"  
[X Link](https://x.com/RebellioMarket/status/1998616070366826918) [@RebellioMarket](/creator/x/RebellioMarket) 2025-12-10T04:49Z 150.6K followers, 2940 engagements


"@Long56102546 @MMatters22596 Based on replies in the thread $SOFI and $ASTS are the most frequently picked stocks to double first. From my analysis of analyst targets and growth potential I'd highlight $IREN and $NBIX as strong contenders toonot financial advice"  
[X Link](https://x.com/grok/status/1998546397508022406) [@grok](/creator/x/grok) 2025-12-10T00:12Z 6.8M followers, XXX engagements


"So damn bullish here $SMMT $ZGNX $IONS $PASG $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS $BMRN $ALEC $ALLO $SUPN $TRVI $BIIB $ARVN $ZURA $NVAX $JAZZ $IDYA $INCY $EXEL $CMRX $ALKS $ABCL $DAWN $ICPT"  
[X Link](https://x.com/BuyTheUgly/status/1998485971441221713) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:12Z XX followers, XXX engagements


"Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"  
[X Link](https://x.com/BuyTheUgly/status/1998485125680738411) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:09Z XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences (NBIX) stock hits a 52-week high driven by strong INGREZZA sales, despite a slight miss on EPS estimates. Analysts remain positive, raising price targets due to robust product performance and successful launches.

About Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Neurocrine Biosciences, Inc. (NBIX) trading volume is up XXXXX% from the previous week.
Neurocrine Biosciences, Inc. (NBIX) social dominance is up XXXXXX% from the previous week.
Neurocrine Biosciences, Inc. (NBIX) sentiment is up XXX% from the previous X months.
Neurocrine Biosciences, Inc. (NBIX) engagements is up XXXXX% from the previous week.
Neurocrine Biosciences, Inc. Price hit a 52-Week high of $XXXXXX for the hour
Neurocrine Biosciences, Inc. Price hit an all time of $XXXXXX for the hour

Price: $XXXXXX

Price 24-Hour Time-Series Raw Data
The stock price recently hit a 52-week high, driven by strong Q3 results and record INGREZZA sales. While missed EPS estimates introduced some minor downward pressure, the overall sentiment remains positive due to strong product performance and successful launches, with analysts raising price targets.

24-Hour: -XXXX% 7-Day: XXXX% 30-Day: XXX%

1-Year High: $XXXXXX on 2025-12-10
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #1,078 based on combined combined social and market metrics Daily Average: XXX
X Week: XXXXX +387
X Month: XXXXX +731
X Months: XXXXX +1,020
X Year: XXXXX +934
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2025-05-06

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-01-13
1-Year Low: X on 2025-09-24

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXXX
X Week: XXXXX +18%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX +17%
X Year: XXXXXXXXX +15%
1-Year High: XXXXXXX on 2025-05-05
1-Year Low: XXX on 2025-12-06

Engagements by network (24h): Reddit: X X: XXX YouTube: X

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXXX +438%
X Year: XXXXXX +333%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XX on 2025-12-07

Mentions by network (24h): Reddit: X X: XXX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XXX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +1,131%
X Year: XXXXXX +834%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XX on 2025-12-07

The most influential creators that mention Neurocrine Biosciences, Inc. in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@Andre_AGTC	X	XXXXX	X	XXX
@NightOwlBiotech	X	XXXXX	X	XXX
@BuyTheUgly	X	XX	X	XXX
@monaco_biotech	X	XXXXX	X	XX
@seedytx19	X	XXXXX	X	X

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +33%
X Month: XXX% +38%
X Months: XXX% +30%
X Year: XXX% +46%
1-Year High: XXX% on 2025-07-20
1-Year Low: XX% on 2025-09-13

Most Supportive Themes:

Ingrezza Sales Growth: (40%) Ingrezza sales are increasing market penetration and revenue.
Crenessity Phase X Study: (35%) Positive outcomes from the Crenessity Phase X study boost confidence in Neurocrine's pipeline.
Affordable Growth Potential: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value.

Most Critical Themes:

Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% +0.0055%
X Month: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
X Months: XXXXXX% -XXXXX%
X Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-03
1-Year Low: XXXXXX% on 2025-12-07

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-04-09
1-Year Low: XXXXX% on 2025-04-14

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX +$1.30%
X Month: $XXXXXXXXXXXXXX +$4.20%
X Months: $XXXXXXXXXXXXXX +$24%
X Year: $XXXXXXXXXXXXXX +$18%
1-Year High: $XXXXXXXXXXXXXX on 2025-01-30
1-Year Low: $XXXXXXXXXXXXX on 2025-04-12

Top Neurocrine Biosciences, Inc. Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"New Highs : $AVGO $COLL $FIX $KRYS $LITE $TTMI $AUGO $BELFA $BELFB $CVNA $COHR $FIGS $FCAP $IESC $IRMD $FROG $NBIX $PWR $SND $PATH $VIAV $ARQT $ENVA $MTZ $MDB $RY $SMTC $BCAL $TRX $ALMS $FIVE $HTBK $MS $NUTX $ANAB $NTB $BK $EBC $ECPG $BE $JBL $NVT $NVT $PRIM $VRT $MSFT $FIVE:"
X Link @RebellioMarket 2025-12-10T04:49Z 150.6K followers, 2940 engagements

"@Long56102546 @MMatters22596 Based on replies in the thread $SOFI and $ASTS are the most frequently picked stocks to double first. From my analysis of analyst targets and growth potential I'd highlight $IREN and $NBIX as strong contenders toonot financial advice"
X Link @grok 2025-12-10T00:12Z 6.8M followers, XXX engagements

"So damn bullish here $SMMT $ZGNX $IONS $PASG $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS $BMRN $ALEC $ALLO $SUPN $TRVI $BIIB $ARVN $ZURA $NVAX $JAZZ $IDYA $INCY $EXEL $CMRX $ALKS $ABCL $DAWN $ICPT"
X Link @BuyTheUgly 2025-12-09T20:12Z XX followers, XXX engagements

"Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"
X Link @BuyTheUgly 2025-12-09T20:09Z XX followers, XXX engagements